Terminated PHASE3 INTERVENTIONAL NCT00454402

ALF-STONE: Alfuzosin in Uretheric Stones

Alfuzosin in Uretheric Stones

Sponsor: Sanofi

Interventions Alfuzosin

Updated 6 times since 2017 Last updated: Sep 21, 2007 Started: Aug 31, 2006 Completion: Jul 31, 2007

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

Discontinued due to incomplete recruitment

A PHASE3 clinical study on Prostatic Hyperplasia, this trial is terminated or withdrawn. The trial is conducted by Sanofi and has accumulated 6 data snapshots since 2006. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

6 versions recorded

Jan 2026 — Present [monthly]

Terminated PHASE3
Sep 2024 — Present [monthly]

Terminated PHASE3
Jul 2024 — Sep 2024 [monthly]

Terminated PHASE3
Jan 2021 — Jul 2024 [monthly]

Terminated PHASE3
Jun 2018 — Jan 2021 [monthly]

Terminated PHASE3

▶ Show 1 earlier version

Jan 2017 — Jun 2018 [monthly]

Terminated PHASE3

First recorded

Aug 2006

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Sanofi

Data source: Sanofi

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Lisbon, Portugal